CLEC14A and melanoma: However, another report has suggested that CLEC14A may not serve as a viable antivascular target; this study demonstrated that although implanted tumour growth of LLC and B16F10 melanoma was markedly impaired in CLEC14A knockout mice in comparison to wild‐type littermates, tumour bearing CLEC14A knockout mice died earlier 204.